SCHEMBL16655183

SCHEMBL16655183

COC(=O)C1CC(C(=O)OC)CN(C(=O)O)C1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.44
BRD4 O60885 1/20 0.43
CHRNB2 P17787 2/20 0.42
CHRNA4 P43681 2/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
CHRNA7 P36544 1/20 0.42
POLB P06746 1/20 0.41
TP53 P04637 1/20 0.39
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
MMP2 P08253 1/20 0.37
ANPEP P15144 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1581725 0.91 SMN1; SMN2 (0.47) SMN1; SMN2BRD4CHRNB2CHRNA4CHRNB4
SCHEMBL14167702 0.89 ALDH1A1 (0.40) SMN1; SMN2BRD4CHRNB2CHRNA4CHRNB4
SCHEMBL14638247 0.89 SMN1; SMN2 (0.40) SMN1; SMN2BRD4CHRNB2CHRNA4CHRNB4
SCHEMBL21811379 0.87 SMN1; SMN2 (0.39) SMN1; SMN2BRD4CHRNB2CHRNA4CHRNB4
SCHEMBL1441341 0.83 SMN1; SMN2 (0.36) SMN1; SMN2BRD4CHRNB2CHRNA4CHRNB4
SCHEMBL2484547 0.80 SMN1; SMN2 (0.59) SMN1; SMN2POLBTP53ALDH1A1GAA
SCHEMBL1710473 0.78 BTK (0.49) POLB
SCHEMBL14167555 0.78 SMN1; SMN2 (0.35) SMN1; SMN2BRD4CHRNB2CHRNA4CHRNB4
SCHEMBL18132141 0.77 SMN1; SMN2 (0.56) SMN1; SMN2POLBTP53ALDH1A1
SCHEMBL1297555 0.77 CHRNB2 (0.62) SMN1; SMN2BRD4CHRNB2CHRNA4CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057954-A2 HETEROMAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES Syros Pharmaceuticals, Inc. (US) 2016-08-24 EP disclosed
WO-2015058163-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS, INC. (US) 2015-04-23 WO disclosed